MX2020009335A - Aislamiento continuo de cannabidiol y conversion de cannabidiol a delta 8-tetrahidro cannabinol y delta 9- tetrahidro cannabinol. - Google Patents

Aislamiento continuo de cannabidiol y conversion de cannabidiol a delta 8-tetrahidro cannabinol y delta 9- tetrahidro cannabinol.

Info

Publication number
MX2020009335A
MX2020009335A MX2020009335A MX2020009335A MX2020009335A MX 2020009335 A MX2020009335 A MX 2020009335A MX 2020009335 A MX2020009335 A MX 2020009335A MX 2020009335 A MX2020009335 A MX 2020009335A MX 2020009335 A MX2020009335 A MX 2020009335A
Authority
MX
Mexico
Prior art keywords
sup
tetrahydrocannabinol
cannabidiol
delta
thc
Prior art date
Application number
MX2020009335A
Other languages
English (en)
Inventor
Mark G Tegen
Joon Cho
Original Assignee
Socati Tech Oregon Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Socati Tech Oregon Llc filed Critical Socati Tech Oregon Llc
Publication of MX2020009335A publication Critical patent/MX2020009335A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/32Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/68Purification; separation; Use of additives, e.g. for stabilisation
    • C07C37/70Purification; separation; Use of additives, e.g. for stabilisation by physical treatment
    • C07C37/82Purification; separation; Use of additives, e.g. for stabilisation by physical treatment by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Silicon Polymers (AREA)
  • Polyethers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un procesamiento y purificación a escala industrial de cannabinoides. En las rea-lizaciones alternativas, se proporcionan procesos que comprenden el aislamiento y purificación continuos de cannabinoides y una mayor isomerización del can-nabidiol purificado a ?8-tetrahidro cannabinol (?8-THC) y ?9-tetrahidro cannabinol (?9-THC). En las realizaciones alternativas, se proporcionan procesos para con-vertir ?8-THC en ?9-THC. En realizaciones alternativas, se proporcionan procesos para la escala industrial de aislamiento continuo y 10 purificación de cannabinoides y una mayor isomerización del cannabidiol purificado a ?9-THC.
MX2020009335A 2018-03-07 2019-03-07 Aislamiento continuo de cannabidiol y conversion de cannabidiol a delta 8-tetrahidro cannabinol y delta 9- tetrahidro cannabinol. MX2020009335A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862639608P 2018-03-07 2018-03-07
US201862697920P 2018-07-13 2018-07-13
US201862697923P 2018-07-13 2018-07-13
US201862697926P 2018-07-13 2018-07-13
US201862715545P 2018-08-07 2018-08-07
PCT/US2019/021138 WO2019173582A1 (en) 2018-03-07 2019-03-07 Continuous isolation of cannabidiol and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
MX2020009335A true MX2020009335A (es) 2020-12-03

Family

ID=67845795

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020009335A MX2020009335A (es) 2018-03-07 2019-03-07 Aislamiento continuo de cannabidiol y conversion de cannabidiol a delta 8-tetrahidro cannabinol y delta 9- tetrahidro cannabinol.

Country Status (11)

Country Link
US (1) US20220002259A1 (es)
EP (1) EP3762375A4 (es)
CN (1) CN112105606A (es)
AU (1) AU2019230124B2 (es)
CA (1) CA3093424A1 (es)
CR (1) CR20200417A (es)
GB (1) GB2587918B (es)
IL (1) IL277200B2 (es)
MX (1) MX2020009335A (es)
WO (1) WO2019173582A1 (es)
ZA (1) ZA202006235B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11213558B2 (en) 2017-05-17 2022-01-04 Orochem Technologies, Inc. CBX extraction-isolation process
US10189762B1 (en) 2017-07-07 2019-01-29 Orochem Technologies, Inc. Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
WO2020028198A1 (en) 2018-08-03 2020-02-06 Biomass Oil Separation Solutions, Llc Processes and apparatus for extraction of substances and enriched extracts from plant material
WO2020117688A2 (en) * 2018-12-04 2020-06-11 Orochem Technologies Inc. Process for purifying tetrahydrocannabinol using a chromatographic stationary phase
WO2020248062A1 (en) * 2019-06-11 2020-12-17 Canopy Growth Corporation Improved methods for cannabinoid isomerization
CA3142976A1 (en) * 2019-06-11 2020-12-17 Canopy Growth Corporation Improved methods for converting cannabidiol into delta9-tetrahydrocannabinol under protic reaction conditions
CA3142956A1 (en) * 2019-06-11 2020-12-17 Canopy Growth Corporation Methods for preparing cannabinoids by heterogeneous-acid-promoted double-bond migration
US10799546B1 (en) 2019-07-26 2020-10-13 Biomass Oil Separation Solutions, Llc Modular, integrated process and apparatus for extracting, refining and remediating active substances from plant material
US11826673B2 (en) * 2019-10-25 2023-11-28 Chimera Technology LLC Solvent-less extraction of cannabinoid acids
US10941131B1 (en) * 2019-10-28 2021-03-09 Pure Tonic Concentrates, LLC Conversion of cannabidiol or delta-9 tetrahydrocannabinolic acid to delta-9 tetrahydrocannabinol and delta-8 tetrahydrocannabinol in nontoxic heterogeneous mixtures
CN111239293A (zh) * 2020-03-02 2020-06-05 福建省中科生物股份有限公司 一种萜酚有关物质的hplc-pda检测方法
CN112661739A (zh) * 2020-12-30 2021-04-16 福建省中科生物股份有限公司 一种萜酚类化合物及其与顺铂联用在抗肿瘤医药上的用途
WO2023244646A1 (en) * 2022-06-15 2023-12-21 Zaiput Flow Technologies LLC Systems and methods for separation of chemical species, such as cannabinoids, using multiple liquid phases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10051427C1 (de) * 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
WO2002070506A2 (en) * 2001-03-07 2002-09-12 Websar Innovations Inc. Conversion of cbd to δ8-thc and δ9-thc
GB0222077D0 (en) * 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
CN1997636B (zh) * 2004-07-19 2011-09-28 希莱格有限公司 获得纯四氢大麻酚的方法
TWI436991B (zh) * 2004-11-22 2014-05-11 Euro Celtique Sa 用於純化反-(-)-△9-四氫大麻酚與反-(+)-△9-四氫大麻酚之方法
DE102005028937B4 (de) * 2005-06-22 2009-07-23 Bionorica Ag Verfahren zur Herstellung von Dronabinol
EP3061510A1 (de) * 2015-02-27 2016-08-31 Bionorica Ethics GmbH CPC Verteilungschromatographie von Cannabinoiden
US20170333503A1 (en) * 2015-06-09 2017-11-23 Total Health Care I Process for extraction, separation and purification of cannabinoids, flavonoids and terpenes from cannabis
ES2907623T3 (es) * 2016-05-13 2022-04-25 Symrise Ag Método para purificar compuestos cannabinoides mediante cromatografía de lecho móvil simulado
US11027218B2 (en) * 2016-06-10 2021-06-08 Canopy Growth Corporation Purification and separation techniques for cannabinoids
CN106278828A (zh) * 2016-08-16 2017-01-04 云南汉素生物科技有限公司 一种从工业大麻花叶中提取大麻二酚的方法
CN107011125B (zh) * 2017-05-06 2020-07-28 云南汉木森生物科技有限责任公司 一种富集大麻二酚的方法
CN107337586B (zh) * 2017-08-28 2020-09-04 黑龙江省科学院大庆分院 一种从汉麻中提取纯化大麻二酚的方法

Also Published As

Publication number Publication date
AU2019230124A1 (en) 2020-10-15
IL277200B2 (en) 2024-01-01
CN112105606A (zh) 2020-12-18
CA3093424A1 (en) 2019-09-12
EP3762375A1 (en) 2021-01-13
ZA202006235B (en) 2023-07-26
CR20200417A (es) 2021-03-31
US20220002259A1 (en) 2022-01-06
WO2019173582A1 (en) 2019-09-12
EP3762375A4 (en) 2022-02-16
AU2019230124B2 (en) 2022-04-21
GB2587918A (en) 2021-04-14
GB2587918B (en) 2023-10-11
IL277200B1 (en) 2023-09-01
GB202013994D0 (en) 2020-10-21
IL277200A (en) 2020-10-29

Similar Documents

Publication Publication Date Title
MX2020009335A (es) Aislamiento continuo de cannabidiol y conversion de cannabidiol a delta 8-tetrahidro cannabinol y delta 9- tetrahidro cannabinol.
ES2569669T3 (es) Fitocannabinoides en el tratamiento del cáncer
CO2019014279A2 (es) Proceso para la purificación y separación de cannabinoides a partir de cáñamo seco y hojas de cannabis
NZ597704A (en) Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
FI3743053T3 (fi) Kannabinoidien käyttö epilepsian hoidossa
PE20200676A1 (es) Composicion de cannabis
BR112018075073A2 (pt) composições nasais de canabidiol
CL2017001893A1 (es) Uso de prg4 como agente antiinflamatorio
MX2020006965A (es) Formulacion farmaceutica oral que comprende cannabinoides y poloxamero.
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
MX2019015315A (es) Composiciones y tratamientos para el trastorno del sueño.
IN2014DN09507A (es)
UY36530A (es) Métodos para purificar cannabinoides, composiciones y kits de estos
CA2582289C (en) Inhibition of tumour cell migration
BR112015023513A2 (pt) métodos de purificação de rna
NZ589228A (en) Combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) for the treatment of a brain tumour
DOP2009000213A (es) Estabilizacion de vitaminas b12
MX2021005476A (es) Plantas de cannabis con un perfil de cannabinoides enriquecidas con ¿-9-tetrahidrocannabinol y cannabigerol.
MX2020002761A (es) Lupulina de lupulo criogenico o granulos de tricomas de cannabis.
DE50001610D1 (de) Antioxidative hautpflegemittel
MX2021000024A (es) Composicion de cannabinoides y metodo para tratar el ptsd y/o la ansiedad.
EP3983395A4 (en) IMPROVED PROCESSES FOR CONVERTING CANNABIDIOL TO DELTA 8-TETRAHYDROCANNABINOL
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
FI20031642A0 (fi) Oksapuu-uutteiden uusi käyttö
BR112015017816A2 (pt) instalação de fundição contínua